Skip to main content
SpringerLink
Log in

Radioimmunoscintigraphy in gastroenterology

  • Chapter
Nuclear Medicine in Gastroenterology

Part of the book series: Developments in Nuclear Medicine ((DNUM,volume 18))

  • 51 Accesses

Abstract

The development, general principles and clinical application of radioimmunoscintigraphy to primary and recurrent colorectal cancer is described. The types of monoclonal antibody, anti CEA, B72.3 or PR1A3 are compared and the importance of a good signal through the choice of the radiolabel is explained. The results from 111In labelled and 99mTc labelled antibodies are presented in a clinical context.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Chan S, Sikora K (1987) ‘The potential of oncogene products as tumor markers.’ Cancer Surveys 185–207

    Google Scholar 

  2. Gold P, Freedman SO (1965) ‘Specific carcinoembryonic antigens of the human digestive system.’ J Exp Med 122: 467–481.

    Article  PubMed  CAS  Google Scholar 

  3. Go VLW (1976) ‘Carcinoembryonic antigen, clinical application.’ Cancer 37: 562–566

    Article  PubMed  CAS  Google Scholar 

  4. Moshakis V, Omerod MG, Westwood JN et al. (1982) ‘The site of binding of anti CEA antibodies to CEA in vivo: An immunocytochemical and autoradiographic approach.’ Brit J Cancer 46: 18–21.

    Article  PubMed  CAS  Google Scholar 

  5. Mach JP, Carrel S, Forni M et al. (1980) ‘Tumour investigation of radiolabelled antibodies against carcinoembryonic antigen in patients with carcinoma.’ New Eng Med 303: 5–10.

    Article  CAS  Google Scholar 

  6. Goldenberg DM, Kim EE, Deland FH et al. (1980) ‘Radioimmunodetection of cancer with radioactive antibodies to carcino embryonic antigen.’ Cancer Res 40: 2984–2992.

    PubMed  CAS  Google Scholar 

  7. Granowska M, Jass JR, Britton KE, Northover JMA (1989) ‘A prospective study of the use of 111In labelled monoclonal antibody against carcino embryonic antigen in colorectal cancer and of some biological factors affecting its uptake.’ Int J Colorect Dis 4: 97–108.

    Article  CAS  Google Scholar 

  8. Baum RP, Hertel A, Lorenz M et al. (1989) ‘99mTc labelled anti-CEA monoclonal antibody for tumour immunoscintigraphy: First clinical results.’ Nucl Med Commun 10: 345–352.

    Article  PubMed  CAS  Google Scholar 

  9. Colcher O, Han P, Nuti M, Schlom J (1981) ‘A spectrum of monoclonal antibodies reactive with human mammary tumour cells.’ Proc Natl Acad Sc USA 78: 3199–3203.

    Article  CAS  Google Scholar 

  10. Schlom J, Colcher D, Roselli M et al. (1989) ‘Tumour targetting with monoclonal antibody B72.3.’ Nucl Med Biol 16: 137–142

    CAS  Google Scholar 

  11. Esteban JM, Colcher D, Sugerbaker P et al. (1987) ‘Quantitative and qualitative aspects of radiolocalization in colon cancer patients of intravenously administered Mab B72.3.’ Int J Cancer 39: 50–59

    Article  PubMed  CAS  Google Scholar 

  12. Salvatore M, Lastoria S, Del Vecchio S, Mansi L (1999) ‘Detection of Colon Cancer with radiolabelled monoclonal antibodies. Nucl Med Biol 16: 103–104.

    Google Scholar 

  13. Richman PI, Bodmer WF (1987) ‘Monoclonal antibodies to human colorectal epithelium: markers for differentiation and tumour characterisation.’ Int J Cancer 39: 317–328.

    Article  PubMed  CAS  Google Scholar 

  14. Kohler G, Milstein C (1975) ‘Continuous culture of fused cells secreting antibody of predefined specificity.’ Nature 256: 495–6.

    Article  PubMed  CAS  Google Scholar 

  15. Begent RHJ (1986) ‘Working party on the clinical use of antibodies: operations manual.’ Brit J Cancer 54: 557–568

    Article  Google Scholar 

  16. Committee for Proprietary Medical Products Ad Hoc working party of Biotechnology/Pharmacy. Notes to applicants for Marketing Authorizations on the production and quality control of monoclonal antibodies of Murine origin intended for use in man. Commission of the European Communities III/859/86-EN Rev. 7. Final 1987.

    Google Scholar 

  17. Britton KE (1989) ‘Potential clinical applications of monoclonal antibodies in bringing biotechnology to the market.’ British Institute of Regulatory Affairs. In press.

    Google Scholar 

  18. Prentice T (1989) ‘Cancer Research: Bureaucrats ‘hinder search for cure.’ Times Aug. 30th.

    Google Scholar 

  19. Buraggi GL, Turrin A, Cascinelli N et al. (1985) Immunoscintigraphy with antimelanoma monoclonal antibodies.’ In: L. Donato & K.E. Britton (eds.), Immunoscintigraphy pp. 215–253. London: Gordon & Breach.

    Google Scholar 

  20. Britton KE, Granowska M (1987) ‘Experience with Iodine-123 labelled antibodies for imaging and therapy.’ Scrivastava SC (ed) NATO AS1 Series pp 177–191. New York: Plenum Press.

    Google Scholar 

  21. Britton KE, Granowska M (1987) ‘Radioimmunoscintigraphy in tumour identification cancer surveys.’ G: 247–267.

    Google Scholar 

  22. Siccardi AG, Buraggi GL, Callegaro L et al. (1986) ‘Multicentre study of immunoscintigraphy with radiolabelled monoclonal antibodies in patients with melanoma.’ Cancer Res. 46: 4817–4822.

    PubMed  CAS  Google Scholar 

  23. Bares RE (1989) ‘A brief guide to the practice of Radioimmunoscintigraphy and Radioimmunotherapy in Cancer,’ in Britton KE, Buraggi G (eds), Int J Biol Markers 4: 106–118.

    Google Scholar 

  24. Granowska M, Britton KE, Shepherd J (1983) ‘The detection of ovarian cancer using 1231 monoclonal antibody.’ Radio Biol Radiother (Berlin) 25: 153–160.

    Google Scholar 

  25. Granowska M, Nimmon CC, Britton KE, Mather SJ, Crowther M, Slevin ML, Shepherd JH (1988) ‘Kinetic analysis and probability mapping applied to the detection of ovarian cancer by Radioimmunoscintigraphy.’ J Nucl Med 29: 594–607.

    Google Scholar 

  26. Epenetos AA, Britton KE, Mather S et al. (1982) ‘Targeting of Iodine-123 labelled tumour associated monoclonal antibodies to ovarian, breast and gastrointestinal tumours.’ Lancet ii: 999–1004.

    Google Scholar 

  27. Hnatovitch DH, Layne WW, Childs RL et al. (1983) ‘Radioactive labelling of antibody: a simple and efficient method.’ Science 220: 613–615.

    Article  Google Scholar 

  28. Mather SJ (1987) ‘Labelling with Indium-Ill. Safety and Efficacy of Radiopharmaceuticals,’ in Kristensen K, Norbygaard E (ed), pp 51–56. Dordrecht: Martinus Nijhoff.

    Google Scholar 

  29. Schwarz A, Steinstraesser A (1987) ‘A novel approach to 99mTc labelled monoclonal antibodies.’ J Nucl Med 28: 721 (Abs).

    Google Scholar 

  30. Dukes CE (1932) ‘The classification of cancer of the rectum. ’ J Path Bact 35: 323–332.

    Article  Google Scholar 

  31. Chatal JF, Saccavini JC, Furnoleau Pet al. (1984) Immunoscintigraphy of colon carcinoma.’ J Nuel Med 25: 307–314.

    CAS  Google Scholar 

  32. Day DW, Morson BC (1978) ‘The adenoma carcinoma sequence. In the pathogenesis of colorectal cancer.’ in Morson BC (ed), pp 48–61. Philadelphia: WB Saunders & Co.

    Google Scholar 

  33. Granowska M, Mather SJ, Britton KE et al (1989) ‘A 99mTc labelled monoclonal antibody PR1A3 for Radiommunoscintigraphy, RIS, of colorectal cancer.’ J Nucl Med 30: 748 (Abs).

    Google Scholar 

  34. Goldenberg DM, Ford EH, Lee RE et al. (1989) ‘Initial clinical imaging results with a new 99mTc antibody labelling method.’ J Nucl Med 30: 809 (Abs.)

    Google Scholar 

  35. Bischof-Delaloye A, Delaloye B, Buchegger F et al. (1989) ‘Chimeric mouse-human anti CEA antibody of IgG4 isotype used in a pilot immunoscintigraphy study of patients with colorectal carcinomas.’ J Nucl Med 30: 809 (Abs.)

    Google Scholar 

  36. Epps LA, Sun L, Arevalo M et al. (1989) ‘Technetium (99mTc) labelled genetically engineered chimeric 17–1A G4K/Metallothionein antibody.’ J Nucl Med 30: 794 (Abs).

    Google Scholar 

  37. Jodrell DI, Irvine AT, McCready VR et al. (1989) ‘The use of 131—I-MIBG in the imaging of metastatic carcinoid tumours.’ Br J Cancer 58: 663–664

    Article  Google Scholar 

  38. Krenning EP, Bakker WH, Breeman WAP et al. (1989) ‘Localisation of endocrine-related tumours with radioiodinated analogue of somatostatin.’ Lancet is 242–244.

    Google Scholar 

Download references

Authors
  1. Maria Granowska
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Keith Britton
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Nuclear Medicine, University of Bonn, Bonn, Germany

    J. Biersack

  2. Department of Nuclear Medicine, Dr. Daniel den Hoed Clinic, Rotterdam, The Netherlands

    H. Cox

Rights and permissions

Reprints and permissions

Copyright information

© 1991 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Granowska, M., Britton, K. (1991). Radioimmunoscintigraphy in gastroenterology. In: Biersack, J., Cox, H. (eds) Nuclear Medicine in Gastroenterology. Developments in Nuclear Medicine, vol 18. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-3316-6_15

Download citation

  • DOI: https://doi.org/10.1007/978-94-011-3316-6_15

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-5464-5

  • Online ISBN: 978-94-011-3316-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation